Clari Vest Asset Management LLC Lexicon Pharmaceuticals, Inc. Transaction History

Clari Vest Asset Management LLC

  • $1 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
SELL
$1.06 - $2.33 $338,114 - $743,214
-318,976 Reduced 62.38%
192,398 $209,000
Q2 2023

Aug 14, 2023
BUY
$2.15 - $3.49 $260,607 - $423,033
121,213 Added 31.07%
511,374 $1.17 Million
Q1 2023

May 08, 2023
BUY
$1.99 - $2.68 $797 - $1,074
401 Added 0.1%
390,161 $949,000
Q4 2022

Feb 14, 2023
SELL
$1.8 - $2.56 $5,455 - $7,759
-3,031 Reduced 0.77%
389,760 $744,000
Q3 2022

Nov 10, 2022
BUY
$1.94 - $3.43 $762,014 - $1.35 Million
392,791 New
392,791 $943,000

Others Institutions Holding LXRX

# of Institutions
141
Shares Held
238M
Call Options Held
459K
Put Options Held
133K
View Full List

About LEXICON PHARMACEUTICALS, INC.

LXRX Quotes by TradingView
  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $157M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track Clari Vest Asset Management LLC Portfolio

Follow Clari Vest Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clari Vest Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email